-
April 12, 2019 Lupin launches Testosterone Gel
-
April 11, 2019 Lupin receives FDA approval for Testosterone Gel
-
April 10, 2019 Lupin launches Fluoxetine Tablets USP
-
April 3, 2019 Lupin Bioresearch Centre completes fifth successful U.S. FDA inspection
-
April 2, 2019 Lupin’s Pithampur Unit-3 (Indore) receives EIR from U.S. FDA
-
April 1, 2019 Lupin appoints Ms. Christine Mundkur as an Independent Director
-
April 1, 2019 Lupin launches Tadalafil Tablets USP
-
March 28, 2019 Lupin launches Fluocinonide Ointment USP 0.05%
-
March 27, 2019 Lupin’s Pune Biotech facility receives EU GMP clearance
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications